[Prognostic factors in chemotherapies for acute myeloid leukemia].
Kuriyama
K
K
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D015337:Multicenter Studies as Topic; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis; D014212:Tretinoin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003561:Cytarabine; D014212:Tretinoin